Aegipan Animal Biocare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-01-2025
- Paid Up Capital ₹ 0.33 M
as on 06-01-2025
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 7.60%
(FY 2021)
- Profit -4.63%
(FY 2021)
- Ebitda -532.97%
(FY 2021)
- Net Worth 75.91%
(FY 2021)
- Total Assets 64.80%
(FY 2021)
About Aegipan Animal Biocare
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.33 M, as per Ministry of Corporate Affairs (MCA) records.
Anima Koley, Kalyan Koley, and Sumita Koley serve as directors at the Company.
- CIN/LLPIN
U74999WB2018PTC224743
- Company No.
224743
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Hooghly, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aegipan Animal Biocare Private Limited offer?
Aegipan Animal Biocare Private Limited offers a wide range of products and services, including Plastic Containers & Bottles, Plastic Bottles, Portable Cabins, Office Containers, Kitchen Containers, Stainless Steel Container, Storage Containers, Water Tanks, Industrial Water Tanks.
Who are the key members and board of directors at Aegipan Animal Biocare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalyan Koley  | Director | 22-Feb-2018 | Current |
| Anima Koley | Director | 22-Feb-2018 | Current |
| Sumita Koley | Director | 22-Feb-2018 | Current |
Financial Performance of Aegipan Animal Biocare.
Aegipan Animal Biocare Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 7.6% increase. The company also saw a slight decrease in profitability, with a 4.63% decrease in profit. The company's net worth Soared by an impressive increase of 75.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aegipan Animal Biocare?
In 2021, Aegipan Animal Biocare had a promoter holding of 97.42% and a public holding of 2.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aegipan Animal Biocare?
Unlock and access historical data on people associated with Aegipan Animal Biocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aegipan Animal Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aegipan Animal Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
